Century Therapeutics, Inc.

The current price of IPSC is 2.88 USD — it has decreased by 8.57% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Century Therapeutics, Inc. stocks are traded under the ticker IPSC.

Century Therapeutics, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.

IPSC stock is 15.25% volatile and has beta coefficient of 1.91. Check out the list of the most volatile stocks — is Century Therapeutics, Inc. there?

IPSC earnings for the last quarter are −0.55 USD per share, whereas the estimation was −0.52 USD resulting in a −5.52% surprise. The estimated earnings for the next quarter are −0.55 USD per share. See more details about Century Therapeutics, Inc. earnings.

Century Therapeutics, Inc. revenue for the last quarter amounts to ‪148.00 K‬ USD despite the estimated figure of ‪1.32 M‬ USD. In the next quarter revenue is expected to reach ‪1.67 M‬ USD.

Yes, you can track Century Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

IPSC stock has fallen by 3.68% compared to the previous week, the month change is a 25.39% fall, over the last year Century Therapeutics, Inc. has showed a 9.72% decrease.

Today Century Therapeutics, Inc. has the market capitalization of ‪186.98 M‬, it has decreased by 2.71% over the last week.

No, IPSC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, IPSC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Century Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

IPSC reached its all-time high on Aug 17, 2021 with the price of 32.90 USD, and its all-time low was 1.28 USD and was reached on Oct 31, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 27, 2024, the company has 165.00 employees. See our rating of the largest employees — is Century Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Century Therapeutics, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Century Therapeutics, Inc. stock shows the sell signal. See more of Century Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Century Therapeutics, Inc. future price: according to them, IPSC price has a max estimate of 24.00 USD and a min estimate of 9.00 USD. Read a more detailed Century Therapeutics, Inc. forecast: see what analysts think of Century Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Century Therapeutics, Inc. EBITDA is ‪−115.26 M‬ USD, and current EBITDA margin is ‪−5.02 K‬%. See more stats in Century Therapeutics, Inc. financial statements.